Acadian Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,365
| Closed | -$44K | – | 2052 |
|
|
2021
Q2 | $44K | Sell |
2,365
-24,288
| -91% | -$452K | ﹤0.01% | 1821 |
|
|
2021
Q1 | $476K | Sell |
26,653
-50,705
| -66% | -$906K | ﹤0.01% | 1214 |
|
|
2020
Q4 | $1.19M | Sell |
77,358
-5,359
| -6% | -$82.6K | ﹤0.01% | 934 |
|
|
2020
Q3 | $915K | Buy |
82,717
+21,789
| +36% | +$241K | ﹤0.01% | 939 |
|
|
2020
Q2 | $762K | Buy |
60,928
+55,244
| +972% | +$691K | ﹤0.01% | 1052 |
|
|
2020
Q1 | $64K | Buy |
+5,684
| New | +$64K | ﹤0.01% | 1455 |
|
|
2015
Q4 | – | Sell |
-10,474
| Closed | -$86K | – | 1522 |
|
|
2015
Q3 | $86K | Sell |
10,474
-11,652
| -53% | -$95.7K | ﹤0.01% | 1006 |
|
|
2015
Q2 | $255K | Buy |
22,126
+18,237
| +469% | +$210K | ﹤0.01% | 896 |
|
|
2015
Q1 | $65K | Buy |
3,889
+308
| +9% | +$5.15K | ﹤0.01% | 1064 |
|
|
2014
Q4 | $71K | Buy |
+3,581
| New | +$71K | ﹤0.01% | 1034 |
|